A bill to amend title 38, United States Code, to require the Secretary of Veterans Affairs to designate medical facilities of the Department of Veterans Affairs as innovative therapies centers of excellence, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4031 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4031 To amend title 38, United States Code, to require the Secretary of Veterans Affairs to designate medical facilities of the Department of Veterans Affairs as innovative therapies centers of excellence, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES March 9, 2026 Mr. Gallego (for himself and Mr. McCormick) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs _______________________________________________________________________ A BILL To amend title 38, United States Code, to require the Secretary of Veterans Affairs to designate medical facilities of the Department of Veterans Affairs as innovative therapies centers of excellence, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Innovative Therapies Centers of Excellence Act''. SEC. 2. DEPARTMENT OF VETERANS AFFAIRS DESIGNATION OF INNOVATIVE THERAPIES CENTERS OF EXCELLENCE. (a) In General.--Subchapter II of chapter 73 of title 38, United States Code, is amended by adding at the end the following new section: ``Sec. 7330E. Innovative therapies centers of excellence ``(a) Establishment of Centers.-- ``(1) Designation.--The Secretary, upon the recommendation of the Under Secretary for Health, shall designate not fewer than five medical facilities of the Department as the locations for innovative therapies centers of excellence. ``(2) Establishment and operation.--Subject to the availability of appropriations for such purpose, the Secretary shall establish and operate innovative therapies centers of excellence at the locations designated pursuant to paragraph (1). ``(b) Geographic Distribution